A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
Clinical trial NCT03019185 · COMPLETED
Trial details
- NCT number
- NCT03019185
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2020-10-06
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.